| Date Filed | Type | Description |
| 10/05/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 10/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 09/27/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 08/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/22/2023 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
SC 13G
| Stahl Andrew reports a 9.9% stake in Arch Therapeutics, Inc. |
| 08/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 07/25/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
SC 13G
| BIGGER CAPITAL FUND L P reports a 9.9% stake in Arch Therapeutics, Inc. |
| 07/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events Interactiv... |
| 07/12/2023 |
SC 13G
| Oasis Capital, LLC reports a 10% stake in Arch Therapeutics, Inc. |
| 07/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 04/20/2023 |
8-K
| Quarterly results |
| 03/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 03/09/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/30/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/27/2023 |
SC 13G/A
| Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc. |
| 01/25/2023 |
SC 13G/A
| Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc. |
| 01/23/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/17/2023 |
8-K
| Quarterly results |
| 12/28/2022 |
10-K
| Annual Report for the period ended September 30, 2022 |
| 12/02/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 09/30/2022 |
8-K
| Quarterly results |
| 08/31/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|